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Sequential deletion of the 3.5 kb region immediatelyMutations were introduced into conserved steroido-
upstream of the mouse Mis transcription start site identi-genic factor 1 (SF1)± and SOX9-binding sites within
fied a 180 bp fragment immediately adjacent to the startthe endogenous mouse MuÈ llerian inhibiting substance
site that is capable of directing the expression of a re-(Mis) promoter. Male mice homozygous for the mutant
porter gene in primary rat Sertoli cells (Shen et al., 1994).SF1-binding site correctly initiated Mis transcription
Sequence comparisons of the 180 bp segment amongin fetal testes, although at significantly reduced levels.
different mammalian species identified a conserved 20Surprisingly, sufficient MIS was produced to eliminate
bp motif (MIS-RE-1) (Shen et al., 1994). This motif con-the MuÈ llerian ducts. In contrast, males homozygous
tains a nuclear hormone receptor half site (AGGTCA) thatfor the mutant SOX9-binding site did not initiate
in vitro can bind the orphan nuclear hormone receptorMis transcription, resulting in pseudohermaphrodites.
steroidogenic factor 1 (SF1) (Lala et al., 1992; HondaThese studies suggest an essential role for SOX9 in the
et al., 1993) (Figure 1A). Electrophoretic mobility shiftinitiation of Mis transcription, whereas SF1 appears to
assays (EMSA) showed that mutation of the half site toact as a quantitative regulator of Mis transcript levels,
ATTTCA abolished SF1 binding. In addition, cotransfec-perhaps for influencing non-MuÈ llerian duct tissues.
tion assays indicated that SF1 binds the half site andComparative studies of Mis expression in vertebrates
activates Mis transcription (Shen et al., 1994). The 180indicate that the Mis promoter receives transcriptional
bp fragment was also found to direct the expression ofinputs that vary between species but result in the same
a reporter gene in an Mis-specific pattern in transgenicfunctional readout.
mice (Giuili et al., 1997). However, no reporter expres-
sion was detected when the half site within the 180 bpIntroduction
fragment was mutated. In mice, SF1 is expressed in the
genital ridges of both sexes beginning at E9.0 (IkedaMuÈ llerian inhibiting substance (MIS), also known as anti-
MuÈ llerian hormone (AMH), is an essential component of et al., 1994). As sexual differentiation proceeds, SF1 is
upregulated in the fetal testis and regulated to very lowthe male sexual differentiation pathway in reptiles, birds,
and mammals (Josso et al., 1993). In males, MIS causes levels in the ovaries. Taken together, these studies argue
that SF1 is essential for activating Mis transcription.the regression of the MuÈ llerian ducts, which in mammals
are the progenitors of the oviduct, uterus, and upper A conserved high mobility group (HMG) transcription
factor±binding site is also present in the Mis promoterportion of the vagina. MIS is secreted by Sertoli cells
of the fetal and prepubertal testis. In male mice, Mis approximately 50 bp upstream from the SF1-binding
transcripts are first detected after embryonic day 11.5 site (Figure 1A). It has been suggested that the testis-
(E11.5), increasing through E19.5, then decreasing dra- determining factor SRY may regulate Mis transcription
matically after birth (MuÈ nsterberg and Lovell-Badge, (Haqq et al., 1994), but other studies have failed to show
1991; Hacker et al., 1995). In female mice, Mis transcripts any direct binding of SRY to the Mis promoter (Shen
are first detected 6 days after birth in the granulosa et al., 1994). An Sry-related HMG box gene, Sox9, is
cells of the ovary. This strict temporal and quantitative expressed in sites of chondrogenesis, the central ner-
regulation of Mis expression is essential for the elabora- vous system, and other tissues, including the genital
tion of the male and female phenotypes. ridge (Wright et al., 1995; Kent et al., 1996; Morais da
The Mis gene has been cloned in diverse vertebrate Silva et al., 1996). In mice, at E10.0, Sox9 is expressed
species (Cate et al., 1986; Picard et al., 1986; MuÈ n- in the genital ridges of both male and female embryos.
sterberg and Lovell-Badge, 1991; Haqq et al., 1992; However, at E11.0, Sox9 expression is upregulated in
the male gonad and decreases to undetectable levels
in female gonads (Kent et al., 1996; Morais da Silva et³ To whom correspondence should be addressed (e-mail: rrb@
notes.mdacc.tmc.edu). al., 1996). Humans with heterozygous null mutations for
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Figure 1. Mis Regulatory Mutagenesis
(A) Conserved transcription factor±binding sites in the mouse Mis promoter region. Mutations were introduced in the SF1-binding site (R1,
regulatory mutation-1), the SOX9-binding site (R2, regulatory mutation-2), and in both SF1- and SOX9-binding sites in cis (R3, regulatory
mutation-3).
(B) Strategy for generating targeted Mis regulatory mutations. The mouse Mis gene contains five exons, which are indicated by the dark blue
boxes. The targeting vector possesses 7.3 kb of total homology (blue line). Either a loxPneo1 or PGKneobpA-lox neo expression cassette
(neo) was introduced into the SfiI site of intron 1. The neo cassettes introduce unique EcoRI and EcoRV restriction sites for Southern blot
analysis. A tk expression cassette was included for negative selection. An identical vector was also constructed but without the promoter
mutations as a loxP control. External probes A and C were used for Southern analysis to screen for targeted ES cell clones. The sizes of the
expected restriction fragments recognized by the probes are indicated. (RV), EcoRV site from neo cassette in R1-neo and loxP-neo targeting
vectors. RI and RV, EcoRI and EcoRV sites from neo cassette in R2-neo and R3-neo targeting vectors.
(C) Removal of the neo cassettes. The neo cassettes were removed either in vivo by crosses with Cre-expressing transgenic mice or in vitro
by transient expression of Cre recombinase. The recombination events were detected by Southern analysis of genomic DNA by digestion
with EcoRI and BamHI and hybridized with probe B. **, mutations; B, BamHI; RI, EcoRI; RV, EcoRV; S, SfiI; X, XhoI.
(D) Summary of Mis alleles.
SOX9 develop campomelic dysplasia, a lethal bone mal- the transgenes are of limited length and integrate at
ectopic sites within the genome that often influenceformation syndrome (Foster et al., 1994; Wagner et al.,
1994). Interestingly, approximately 75% of XY SOX9 het- expression. To determine the true in vivo function of the
conserved SF1- and HMG-binding sites within the Miserozygotes also show sex reversal (Mansour et al.,
1995). EMSA and cotransfection experiments have dem- promoter, we have mutated these sites in the endoge-
nous mouse Mis promoter by gene targeting in ES cells.onstrated that SOX9 can bind the conserved HMG site
and activate Mis transcription in COS cells (De Santa Our findings define a complexity in the regulation of Mis
not detected in in vitro and transgenic mouse experi-Barbara et al., 1998; Morais da Silva and R. L.-B., un-
published observations). Furthermore, these studies ments. Furthermore, our in vivo findings in the mouse,
together with recent Mis expression studies in birdsshowed that SOX9 and SF1 could act synergistically to
and reptiles, reveal that the SOX9- and SF1-mediatedactivate the Mis promoter. Thus, Mis transcription may
regulation of Mis transcription is divergent betweenhave multiple regulators to create the complex expres-
mammalian and nonmammalian amniote vertebrates.sion pattern found in male and female mammals.
This illustrates how rapidly evolving sex-determiningAlthough a number of genes involved in sexual devel-
mechanisms can still lead to the same downstreamopment have been molecularly defined, their precise
events critical for vertebrate sexual development.positions and relationships in this developmental path-
way remain unclear (Swain and Lovell-Badge, 1999). In
Resultsvitro assays are useful for suggesting which factors can
interact with specific cis elements to regulate gene tran-
scription. However, their in vivo relevance cannot be Generation of Mice with Targeted Mis
Promoter Mutationsdetermined using these assays. Although transgenic an-
imals provide a useful in vivo assay system for investi- To generate mice with specific transcription factor±
binding site mutations in the endogenous Mis promoter,gating the activity of transcription factor±binding sites,
Genetic Pathways of Vertebrate Sexual Development
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Figure 2. Screening of Mis Regulatory Mu-
tant Alleles
(A) Southern blot analysis of Mis targeted
clones. R1-neo or loxP-neo targeted clones
digested with EcoRI/EcoRV produce 12.5 kb
wild-type and 6.4 kb targeted bands when
hybridized to an external Mis 59 probe. R2-
neo and R3-neo targeted clones digested
with EcoRI/EcoRV produce 12.5 kb wild-type
and 8.4 kb targeted bands when hybridized to
the external Mis 59 probe. All targeted clones
digested with EcoRI/EcoRV produce 12.5 kb
wild-type and 7.1 kb targeted bands when
hybridized to an external Mis 39 probe.
(B) Southern blot genotyping of tail DNA from
males with Mis regulatory mutations. EcoRI/
BamHI digested genomic DNA was hybrid-
ized with probe B. Shown are 4.5 kb wild-
type, 3.2 kb neo positive alleles, and 1.3/1.2
neo negative alleles.
(C) Sequence analysis of the Mis promoter
region. PCR primers (arrows) were designed
to flank and amplify the mutated region. DNA
sequencing was performed on the targeting
vectors, targeted ES cell clones, and homo-
zygous mutant animals (shown) to detect the
presence of the mutations and the absence
of any unwanted modifications introduced
during the mutagenesis strategy.
we used a Cre recombinase/loxP gene targeting strat- for the in cis SF1- and SOX9-binding site mutations with
the neo cassette. The Mis regulatory mutations in whichegy. In this strategy, the transcription factor±binding site
mutations were introduced by site-directed mutagene- the neo cassette has been removed by Cre recombinase
were designated R1, R2, and R3, respectively. The con-sis into the 59 arm of homology of the targeting vector
(Figures 1A and 1B). The alterations in the transcription trol Mis allele with the neo cassette was designated
loxP-neo. The Mis control allele in which the neo cas-factor±binding sites did not include base pair additions
or deletions because the exact spacing between the sette has been removed was designated loxP. A sum-
mary of the Mis alleles generated in this study are listedconserved elements may be functionally important. For
positive selection, a loxP-flanked (floxed) neo expres- in Figure 1D.
Targeted ES cell clones were initially identified bysion cassette was placed within intron 1 in reverse orien-
tation relative to Mis transcription. The presence of ex- Southern analysis (Figure 2A). Targeted ES cell clones
were then analyzed by PCR and DNA sequencing toogenous selectable marker sequences can influence the
activity of a targeted locus (Pham et al., 1996). Therefore, confirm the presence of the SF1- and SOX9-binding site
mutations and to ensure that no other changes wereafter targeted ES cell clones or mice containing the Mis
alleles with the neo cassette were obtained, the neo introduced into the promoter region (Figure 2C). Cor-
rectly targeted ES cell clones were microinjected intocassette was removed by Cre recombinase expression,
leaving a single loxP site within intron 1 (Figure 1C). blastocysts. A total of ten independent ES cell clones
representing at least two each of the mutant and controlMice that had a wild-type Mis promoter region and a
single loxP site within intron 1 were also generated to vectors contributed to the germline of the resulting chi-
meras.control for the potential effects that a single loxP site in
intron 1 might have on Mis transcription.
Mutant and control gene targeting vectors differing in The SF1-Binding Site within the Mis Promoter Is Not
Essential for MuÈ llerian Duct Regressiontheir SF1 and SOX9 response elements were generated.
The SF1-binding site mutation we generated in the Mis The reproductive tracts of 6-week-old males carrying
either the SF1-binding site mutation R1-neo or the con-promoter was identical to the 2 bp mutation previously
documented in in vitro and transgenic mouse studies trol loxP-neo alleles were analyzed (Figure 3). Male mice
heterozygous for R1-neo or loxP-neo had normal repro-(Shen et al., 1994; Giuili et al., 1997) (Figure 1A). The
mutant SOX9-binding site was created by scrambling ductive tracts. In contrast, both R1-neo/R1-neo and
loxP-neo/loxP-neo males developed as internal pseudo-the sequence (Figure 1A). This prevented SOX9 binding
as shown in gel shift assays (Ryohei Sekido and R. L.-B., hermaphrodites retaining MuÈ llerian duct derivatives (a
uterus and oviducts) in addition to their normal maledata not shown). The mutant targeting vectors and
their resulting Mis alleles were designated regulatory reproductive organs (Figure 3). This phenotype was
identical to the reproductive tract abnormalities pre-mutation-1-neo (R1-neo) for the SF1-binding site muta-
tion with the neo cassette, regulatory mutation-2-neo viously reported for Mis-null male mice (Behringer et al.,
1994). These results suggest that the neo cassette was(R2-neo) for the SOX9-binding site mutation with the
neo cassette, and regulatory mutation-3-neo (R3-neo) disrupting Mis expression.
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412
Figure 3. Gross Dissection of the Internal Reproductive Organs of Adult Male Mice with MIS-neo Alleles Reveals Pseudohermaphroditism
Wild-type (1/1) and R1-neo/1 mice show a normal phenotype. The loxP-neo/loxP-neo and R1-neo/R1-neo mice develop as pseudohermaphro-
dites with a uterus (arrow) and oviducts. The male and female reproductive organs run parallel to each other joined by connective tissue that
has been cut to reveal the dual nature of the organs. Arrowhead, vas deferens; b, bladder; sv, seminal vesicle; t, testes.
To eliminate interference by the neo cassette on Mis males stained positive for b-gal activity, while these
structures in R1/R1-neo males without the MRKI markertranscription, the floxed neo cassette was removed from
the R1-neo and loxP-neo alleles (Figure 2B). The repro- were negative for b-gal activity (Figure 4C). The repro-
ductive tracts of the R1/R1-neo; MRKI/1 males wereductive tracts of 6-week-old R1/R1 and loxP/loxP males
were dissected and analyzed (Figure 4). Gross examina- embedded in paraffin and sectioned. In 1/1; MRKI/1
adult females, b-gal activity was detected in the longitu-tion of R1/R1 and loxP/loxP males revealed the presence
of only male reproductive organs (Figure 4A). Closer dinal muscle layer of the uterine body and horns. The
retained presumptive uterine tissue in the R1/R1-neo;observation showed that male mice homozygous for
either R1 or loxP alleles have normal reproductive tracts MRKI/1 males expressed b-gal activity in an identical
pattern (data not shown). Taken together, these resultswith no retention of MuÈ llerian duct±derived tissues (Fig-
ure 4B). These results indicate that the SF1-binding site indicate that the retained tissue in the R1/R1-neo males
is of MuÈ llerian duct origin and is composed of the uterinein the Mis promoter is dispensable for normal male sex-
ual development. We next combined the R1-neo allele body and proximal uterine horns. These genetic results
indicate that the R1 allele is a hypomorph with reduced(functionally equivalent to a null) with the loxP and R1
alleles to further reduce Mis expression. loxP/R1-neo Mis expression relative to wild type.
compound heterozygous males were normal with com-
plete MuÈ llerian duct regression (Figure 4B). Interestingly, The SF1-Binding Site within the Mis Promoter
Is Required for the Upregulationthe MuÈ llerian ducts of R1/R1-neo compound heterozy-
gous males were only partially regressed (Figure 4B). of Mis Transcription
MIS is secreted by the fetal testis and may act first onAlthough the R1/R1-neo males partially retained uterine
tissue, they all proved to be fertile. the region of the MuÈ llerian duct closest to the testis,
requiring either a constant production or higher concen-To document that the residual tissue in the R1/R1-
neo males was truly uterine tissue of MuÈ llerian duct trations, or both, of MIS to reach the farthest region of
its target organ to cause it to regress. MuÈ llerian ductsorigin, a lacZ reporter cassette was introduced into the
Mis type II receptor gene by homologous recombina- are only sensitive to MIS action during a narrow window
in development, suggesting that either low or delayedtion. The targeted allele was designated MIS receptor
knockin (MRKI). MRKI/1 females express b-galactosi- Mis expression from the R1 allele may be responsible
for the partial regression of the MuÈ llerian ducts in thedase (b-gal) activity during embryogenesis in the MuÈ lle-
rian ducts and subsequently in the adult in the uterus R1/R1-neo males.
To compare the onset of Mis expression from theand oviducts (Figure 4C). The details of these mice will
be reported elsewhere. R1/R1 males were mated to R1- R1 allele to that of the wild-type allele, we performed
RT±PCR and RNase protection assays (RPA) on embry-neo/1 females carrying MRKI to generate R1/R1-neo;
MRKI/1 males. After X-gal staining, the retained presump- onic and postnatal testes. RNA was extracted from
E11.5 and E12.5 R1/R1 and 1/1 genital ridges. Becausetive uterine tissue in 6-week-old R1/R1-neo; MRKI/1
Genetic Pathways of Vertebrate Sexual Development
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Figure 4. Phenotype of Adult Male Reproductive Tracts with Control or Mutant Mis Alleles after neo Removal
(A) loxP/loxP (control) and R1/R1 males as well as the compound heterozygous loxP/R1-neo (control) and R1/R1-neo males are grossly normal.
R2/R2 and R3/R3 animals develop as pseudohermaphrodites, characterized by the retention of female reproductive organs in an otherwise
virilized male. The arrow points to the uterus.
(B) Partial retention of MuÈ llerian duct tissue in R1/R1-neo males. Detailed view of the male reproductive organs. R1/R1 and control loxP/R1-
neo males have a wild-type (1/1) phenotype (arrow, adipose tissue; arrowhead, vas deferens). R1/R1-neo males have apparently partially
retained uterine structures (arrow).
(C) Persistent uterine tissue in R1/R1-neo males. To provide conclusive evidence on the origin of the retained tissue, a lacZ knockin into the
MIS type II receptor gene (MRKI) was utilized. MRKI is expressed as b-gal activity in the MRKI/1 female uterus. MRKI/MRKI males are
pseudohermaphrodites because the MIS type II receptor is essential for MuÈ llerian duct regression (Imbeaud et al., 1995; Mishina et al., 1996).
The retained uterus in MRKI/MRKI males expresses b-gal activity (arrow). The retained tissue of the R1/R1-neo; MRKI/1 males also expresses
b-gal activity (arrow), demonstrating that the tissue is of MuÈ llerian duct origin. As a control, R1/R1-neo males without MRKI were also analyzed.
The retained tissue (arrow) does not have endogenous b-gal activity. Arrowhead, vas deferens.
sexing by morphology is not possible until E12.5, PCR there was a dramatic reduction in Mis transcript levels
from the R1 allele. Interestingly, the same low level ofamplification of the Y chromosome±specific gene Sry
was performed to determine the sex of the E11.5 em- expression was maintained until 12 dpp when it became
undetectable, a stage when wild-type and loxP allelesbryos (Gubbay et al., 1990). Mis expression was first
detected at E12.5 in both R1/R1 and 1/1 testes by were still being transcribed. Quantitation of the Mis tran-
script levels showed a greater than 3-fold decrease inRT±PCR (Figure 5A). These results indicate that the on-
set of Mis expression is not affected in the R1/R1 mu- the levels of Mis expression from the R1 allele in compar-
ison with controls (Figure 6B). These results provide atants. We next quantitated Mis expression in R1/R1 tes-
tes during embryogenesis and postnatal development molecular confirmation that expression from the R1 al-
lele is reduced.by RPA (Figure 6A). R1/R1, R1/R1-neo, and 1/1 RNA
was isolated from E13.5, E15.5, 9 dpp, and 12 dpp tes-
tes. As a control loxP/loxP RNA from E15.5 and 12 dpp The SOX9-Binding Site within the Mis Promoter
Is Essential for MuÈ llerian Duct Regressiontestes was also isolated. RPAs showed that the pattern
of expression from the wild-type Mis allele was similar to We next explored the role of the conserved SOX9-bind-
ing site in the Mis promoter on the regulation of Misthat previously reported (Hacker et al., 1995). In contrast,
Cell
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Figure 5. RT±PCR Analysis of Mis Transcription in the Fetal Testes
of R1/R1 and R2/R2 Mice
(A) RT±PCR shows a normal onset of Mis transcription in R1/R1
Figure 6. Mis Expression Levels from the R1 Alleletestes. Embryonic ovaries and postnatal testes served as negative
(A) RPA analysis of Mis transcription from the R1 and loxP allelesand positive Mis controls, respectively. Ubiquitously expressed Hprt
in testes. RPA shows that the level of transcription from the R1was used as an internal control. The upper band (*) in some lanes
allele in testes is significantly lower than that of wild type duringis amplified genomic DNA for the Mis locus.
embryogenesis and postnatal development. At 12 dpp, a time when(B) RT±PCR shows the absence of Mis transcripts in R2/R2 testes,
wild-type Mis is still being expressed, no Mis transcripts are de-whereas R2/1 testes express Mis.
tected from the R1 allele. loxP/loxP testicular RNA was used to
measure any effect that the loxP sequence might have on Mis tran-
scription. Liver RNA, negative control; ribosomal 18S probe, internal
transcription. Males homozygous for the R2 allele were control.
(B) Quantitation of Mis RNA levels. Although Mis levels in R1/R1sacrificed at 6 weeks of age, and their reproductive
testes (blue bar) are more than 3-fold lower than wild type (yellowtracts were dissected and analyzed. R2/R2 and R2/R1-
bar), these animals have completely regressed MuÈ llerian ducts. R1/neo males were internal pseudohermaphrodites with
R1-neo males (red bar) have an additional slight decrease in Miscomplete retention of MuÈ llerian duct±derived organs levels, and, as shown, they partially retain MuÈ llerian duct tissue.
(Figure 4A), identical in phenotype to Mis-null male mice. loxP/loxP controls (green bar) express wild-type levels of Mis tran-
These results suggest that the expression of Mis from scripts.
the R2 allele is below the threshold required for complete
MuÈ llerian duct regression. Perhaps not surprisingly, the
R3 allele, which includes both SF1- and SOX9-binding Discussion
site mutations in cis, behaved exactly like the R2 allele.
In mammals, SRY initiates the conversion of the undiffer-
entiated fetal gonad into a testis (Goodfellow and Lovell-The SOX9-Binding Site within the Mis Promoter
Is Essential for Transcriptional Initiation Badge, 1993). However, in birds and reptiles, no SRY
gene has been identified, suggesting that other mecha-We next examined the molecular phenotype of the R2
allele. To determine the onset of R2 expression, we nisms initiate the formation of testes in these verte-
brates. Yet in both mammalian and nonmammalian am-collected RNA from E12.5 testes, a time when Mis ex-
pression from the wild-type and R1 alleles was first niotes, MIS and testosterone are subsequently secreted
by the developing testis to mediate the regression ofdetected. RT±PCR showed no detectable transcripts
from R2/R2 testes, indicating an absence of Mis tran- the MuÈ llerian duct system and virilization of the internal
and external genitalia, respectively. Thus, the MIS sig-scription initiation at E12.5 (Figure 5B). To determine
whether the onset of Mis transcription from the R2 allele naling pathway for MuÈ llerian duct regression is one of
the primary and essential processes of male sexual de-had been delayed to a later embryonic time point, we
collected E15.5 testicular RNA. E15.5 was chosen be- velopment.
The Mis gene is expressed in a complex, sexuallycause this is the time when MuÈ llerian ducts are actively
regressing. RT±PCR showed an absence of Mis tran- dimorphic pattern. This complex expression pattern is
likely to be regulated by numerous transcriptional in-scripts in R2/R2 testes, whereas expression was ob-
served in R2/1 testes (Figure 5B). These results demon- puts. We have analyzed the in vivo relevance of two
evolutionarily conserved transcription factor±bindingstrate that the SOX9-binding site is essential for Mis
transcription in vivo. sites within the mouse Mis promoter. These regulatory
Genetic Pathways of Vertebrate Sexual Development
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hormone. Similar findings were reported by Jost (1953)
who showed that testicular grafts into female fetal rab-
bits caused the regression of the MuÈ llerian ducts only
on the grafted side of the fetus. However, the regression
of the MuÈ llerian duct system in the bovine freemartin
suggests that MIS can also act as a circulating hormone.
More studies will be required to determine how MIS
reaches its target organs. The R1/null male mice were
fertile despite the low Mis levels and the presence of
some MuÈ llerian duct±derived structures. Male North
American beavers typically retain residual uterine tissue
(Meier et al., 1998). This raises the possibility that there
may be fertile human males with variable levels of MIS
Figure 7. Model for Mis Transcription in Sertoli Cells of the Male that unknowingly retain some uterine tissue.
Gonad The observation that male mice homozygous for the
The current data suggest that Mis transcription is initiated by SOX9 SF1-binding site mutation have complete regression of
acting through the conserved HMG site of the Mis promoter. In the the MuÈ llerian duct system despite significantly reduced
absence of an HMG-binding site, no Mis transcription is initiated,
levels of Mis expression demonstrates that normal MISleading to the retention of MuÈ llerian duct±derived tissues. After the
levels are in many fold excess. Perhaps this excessinitiation of Mis transcription by SOX9, expression is upregulated by
serves as a guarantee that males do not differentiateSF1 binding to the nuclear hormone half site and physical interaction
with SOX9. The upregulation of Mis transcription by SF1 may func- female reproductive organs that would compromise fer-
tion to regulate non-MuÈ llerian duct cell types, such as Leydig cells. tility. Another possibility, which is not mutually exclusive,
A specific isoform of WT1 has been shown to physically interact with is that SF1 upregulates Mis expression to levels neces-
SF1 to synergistically upregulate Mis transcription. In the absence of sary for its action on non-MuÈ llerian duct tissues.an SF1-binding site, SF1 is unable to bind the Mis promoter, resulting
The MIS type II receptor is expressed in the mesen-in the observed decrease in Mis levels. These levels are still sufficient
chymal cells surrounding the MuÈ llerian ducts, Sertolifor complete regression of the MuÈ llerian ducts. GATA4 may also
have a role in the initiation of Mis transcription through binding of and Leydig cells of the testis, and granulosa cells of the
the conserved GATA site, perhaps through interactions with SOX9. ovary (Baarends et al., 1994, di Clemente et al., 1994;
However, the timing of GATA4 expression indicates that it, like SF1, Racine et al., 1998; Lee et al., 1999). High levels of MIS
may also function as a quantitative regulator of Mis transcription. have been shown in transgenic mice to reduce circulat-
GATA4 levels upregulate in males at E13.5 and downregulate after
ing testosterone levels, sometimes causing an absencebirth, correlating with the postnatal decrease in Mis transcription.
of virilization (Behringer et al., 1990; Lyet et al., 1995).GATA1 levels initiate soon after birth and correlate with the decrease
The high levels of MIS in these transgenic mice caused ain GATA4 and Mis levels. Thus, the conserved GATA site in the Mis
promoter may interact with both GATA1 and GATA4 to modulate disruption in the differentiation of Leydig cell precursors
Mis levels. (Racine et al., 1998). In addition, a proportion of older
Mis-null mice develop Leydig cell hyperplasia (Behringer
et al., 1994). Furthermore, an MIS deficiency leads to
mutants have revealed complexities not detected in
enhanced testicular tumorigenesis, including Leydig cell
vitro, nor even in standard transgenic mouse assays.
tumors, when combined with an a-inhibin deficiency
Our in vivo results indicate a hierarchy of transcription (Matzuk et al., 1995). Thus, the upregulation of Mis
factors controlling the expression of Mis in Sertoli cells caused by SF1 in the male fetus may serve to modulate
that is essential for proper development of the male Leydig cell function and not MuÈ llerian duct regression.
phenotype. A model for Mis transcription based upon Males homozygous for the SF1-binding site mutation
our findings and previously published results is pre- initiated Mis transcription with correct timing that was
sented in Figure 7. maintained throughout embryogenesis, suggesting that
SF1 is not essential for the maintenance of Mis transcrip-
SF1 Is a Quantitative Regulator of Mis Transcription tion. However, Mis transcript levels from the R1 allele
but Is Not Essential for MuÈ llerian Duct Regression became undetectable by 12 dpp, a time when wild-
Our in vivo results obtained in the context of the natural type Mis transcripts are still detected (MuÈ nsterberg and
locus demonstrate that the SF1-binding site in the Mis Lovell-Badge, 1991; Hacker et al., 1995). Thus, it is pos-
promoter is not required for the initiation of Mis tran- sible that SF1 may be required for the postnatal mainte-
scription, but rather for its upregulation during em- nance of Mis transcription. Alternatively, because Mis
bryogenesis. Surprisingly, although males homozygous transcription from the R1 allele is generally low, the lack
for the SF1-binding site mutation (R1/R1) had dramati- of Mis transcripts at 12 dpp may be due to the normal
cally reduced levels of Mis transcripts, regression of the downregulation of Mis after birth (MuÈ nsterberg and Lov-
MuÈ llerian duct system proceeded to completion. It was ell-Badge, 1991; Hacker et al., 1995).
not until the R1 and null alleles were combined, dropping One factor that may interact with SF1 to upregulate
the levels of Mis even further past a critical threshold, Mis transcription is the Wilms' tumor suppressor, WT1
that MuÈ llerian duct tissue was partially retained. Inter- (Call et al., 1990). Both SF1 and WT1 are required in
estingly, the MuÈ llerian duct±derived tissues that per- mice for the formation of gonads (Kreidberg et al., 1993;
sisted were those farthest away from the source of MIS Luo et al., 1994). Interestingly, a specific isoform of WT1
production, the testes. These results are consistent with has been reported to physically interact with SF1 to
the idea that MIS may function in a local manner for synergistically activate the Mis promoter through the
SF1-binding site in vitro (Nachtigal et al., 1998). TheMuÈ llerian duct regression rather than as a circulating
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synergism between SF1 and WT1 for Mis transcription individuals with PMDS that lack mutations within the
Mis coding region (Josso et al., 1997). Evidence fromcan be antagonized by the nuclear receptor DAX1
through physical interactions with SF1 (Muscatelli et al., human genetics suggests that SOX9 is a key sex-
determining gene (Foster et al., 1994; Wagner et al.,1994; Swain et al., 1996; Nachtigal et al., 1998). Thus,
SF1 may serve as a nexus for modulating Mis expression 1994). Our results suggest that in addition to its sex-
determining role, SOX9 also regulates Mis, a gene prod-levels once transcription has been initiated.
It is formally possible that Mis transcription in the uct that is directly involved in sexual differentiation.
Thus, in mammals, SOX9 may be a master regulator oftestes of R1/R1 males could also be explained by the
existence of redundant SF1-binding sites. However, in sexual development.
There must be other factors, in addition to SOX9, thatvitro studies have demonstrated the absence of addi-
tional functional SF1-binding sites within 23.2 kb from are required to activate Mis transcription specifically in
fetal Sertoli cells because SOX9 is expressed in manythe Mis transcription start site (Giuili et al., 1997). We
have scanned the Mis gene for other putative SF1-bind- other tissues that do not express Mis (Wright et al., 1995;
Kent et al., 1996; Morais da Silva et al., 1996). The SOX9-ing sites and have found related sites. However, these
sites differ from the consensus SF1 binding sequence containing transcription factor complex that initiates Mis
transcription in fetal Sertoli cells may then be modifiedeither within or at the first three nucleotides 59 of the
half site. These three nucleotides are necessary for SF1 by other factors such as SF1 to modulate Mis transcrip-
tion up or down. One transcription factor that may alsobinding specificity (Morohashi et al., 1992; Wilson et
al., 1993). Interestingly, the Sap62 locus is approxi- cooperate with SOX9 to initiate or modulate Mis tran-
scription is GATA4 (Arceci et al., 1993; Tremblay andmately 300 bp immediately upstream of the Mis tran-
scription start site (Dresser et al., 1995). Sap62 encodes Viger, 1999). A conserved GATA factor±binding site is
located about 10 bp downstream from the SF1-bindinga spliceosome protein that is ubiquitously expressed
and is transcribed in the same orientation as Mis. Thus, site in the mammalian Mis promoters (Figure 1A). GATA4
can bind this site and activate the 2180 bp Mis promotera ubiquitously expressed gene resides adjacent to a
gene that is expressed in a complex pattern. The coevo- in vitro (Viger et al., 1998). GATA4 protein is detected
at E11.5 in the genital ridge of both male and femalelution of these two genes may have imposed physical
constraints on the placement of the Mis regulatory ele- mice. In males, levels of GATA4 increase at E13.5, are
maintained during embryogenesis, but are then down-ments, forcing them to be located within this small in-
tergenic region. Regardless of the presence of other regulated by 14 dpp (Viger et al., 1998; Ketola et al.,
1999). In females, GATA4 expression is downregulatedfunctional SF1-binding sites associated with the Mis
locus, we show that the site located within the proximal by E16.5 but is expressed in adult granulosa cells. Thus,
it is possible that GATA4 may act with SOX9 to initiatepromoter is required for increasing Mis transcript levels.
It is still possible that SF1 may contribute to the low Mis transcription. In vivo studies to address the role of
the GATA-binding site on the transcriptional regulationlevels of Mis expression observed in the R1/R1 testes
through its physical interaction with SOX9 (De Santa of Mis are currently under investigation.
Barbara et al., 1998). Thus, it may form an essential part
of a transcription factor complex at the Mis promoter, Defining Genetic Pathways of Vertebrate
without direct contact with DNA, as suggested for WT1 Sexual Development
(Nachtigal et al., 1998). This issue may be resolved by Although in vitro and even transgenic mouse assays
generating a Sertoli cell±specific inactivation of Sf1 gene have indicated which factors potentially regulate Mis
function. transcription, it has not been clear how these factors
truly act in vivo. Our in vivo studies clearly define the
requirement of the SOX9-binding site within the mouseSOX9 Is Required to Initiate Mis Transcription
Haqq et al. (1994) showed that SRY could activate a 114 Mis promoter for initiating Mis transcription and a quan-
titative role for the SF1-binding site. The high degree ofbp human Mis promoter in vitro. Although mutation of
the SRY protected region abolished SRY binding, it did sequence conservation within the promoter regions of
the cloned mammalian Mis genes suggests that the ac-not alter the transcriptional response of the Mis pro-
moter to SRY, suggesting that SRY does not directly tivities of the transcription factor±binding sites that we
have defined here are likely to be functionally conservedregulate Mis transcription. In contrast, in vitro studies
have demonstrated the necessity of SOX9 and its bind- in mammals. Surprisingly, recent studies in the chick and
alligator demonstrate that Mis transcripts are expresseding site in the Mis promoter for transcriptional activity
(De Santa Barbara et al., 1998). However, recent in vitro prior to SOX9 expression (Oreal et al., 1998; Western et
al., 1999). Thus, in contrast to mammals, the initiationstudies have questioned the role of SOX9 in the sex-
specific regulation of Mis (Tremblay and Viger, 1999). of Mis transcription appears to be independent of SOX9
in nonmammalian amniotes.Our in vivo results demonstrate that the SOX9-binding
site within the mouse Mis promoter is essential for the In eutherian mammals, sex determination is geneti-
cally regulated, whereas sexual differentiation is con-initiation of Mis transcription. Male mice homozygous
for the SOX9-binding site mutation completely retained trolled by gonadal hormones. Thus, alterations in gonadal
hormone levels in the fetuses of eutherian mammalsMuÈ llerian duct±derived organs due to a complete ab-
sence of Mis expression. This suggests that SOX9 is an have no effects on sex determination. In contrast, sex
determination in amphibians, fish, reptiles, and birds canessential activator of Mis transcription. Thus, mutations
in the SOX9-binding site of the human Mis promoter be greatly influenced by steroid hormones. For example,
the administration to chick embryos of an aromatasemay provide a molecular explanation for MIS-deficient
Genetic Pathways of Vertebrate Sexual Development
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Generation of Targeted ES Cell Clones and Germline Allelesinhibitor that blocks the conversion of testosterone to
The Mis vectors were linearized with NotI outside the 39 homology.estrogen can convert genetic females into fertile males
AB1 ES cells (1.0 3 107) (McMahon and Bradley, 1990) were electro-(Elbrecht and Smith, 1992). In turtles, alligators, and
porated independently with 25 mg of each vector and selected for
lizards with temperature-dependent sex determination, 10 days in G418 and FIAU medium. A total of 300±600 G418r, FIAUr
estrogen treatment at male-producing temperatures ES cell colonies for each vector were picked and analyzed by South-
ern blot (Ramirez-Solis et al., 1992) with 59 and 39 external probescan result in ovarian development (Pieau et al., 1994),
as previously described (Behringer et al., 1994) (Figure 1C). For loxP-whereas in turtles androgen treatment at female-pro-
neo and R1-neo, correctly targeted ES cell clones were identifiedducing temperatures can induce testis formation (Wib-
by the presence of additional 6.4 kb and 7.1 kb bands when digestedbels et al., 1992). In fish, androgen treatment can con-
with EcoRI/EcoRV and hybridized with 59 and 39 external probes,
vert genetic females into fertile males, and estrogen respectively (Figure 2A). ES cell clones targeted with either R2-neo
treatment can convert genetic males into females (Baroil- or R3-neo were identified by the presence of additional 8.4 kb and
7.1 kb bands when digested with EcoRI/EcoRV and hybridized withler et al., 1999). Thus, there are fundamental differences
the same 59 and 39 probes, respectively (Figure 2A). Targeting fre-in sex determination pathways between mammalian
quencies of 1/9, 1/9, 1/14, and 1/6 G418r, FIAUr ES cell coloniesand nonmammalian vertebrates. However, downstream
screened for R1-neo, R2-neo, R3-neo, and loxP-neo were obtained,events such as Mis expression and regression of the
respectively.
MuÈ llerian duct system are conserved among amniote Correctly targeted ES cell clones were injected into 3.5 days post-
species. Interestingly, the sequence and organization of coitum (dpc) C57BL/6 (B6) blastocysts, which were in turn trans-
ferred into 2.5 dpc Swiss foster mothers. High-percentage chimerasthe chick Mis promoter region is dramatically divergent
(80%±100% agouti pigmentation) were obtained for all of the Misfrom the sequence of mammalian Mis promoters (Oreal
clones. Male chimeras were bred to B6 females, and their agoutiet al., 1998). An SF1-binding site is located 5 bp up-
pups were genotyped to confirm germline transmission of the tar-stream of the TATA box, putative HMG-binding sites are
geted alleles.
scattered more 59 prime, and no obvious GATA-binding
sites are apparent. It is intriguing to note that SF1 also Cre Recombinase±Mediated Excision of neo
regulates cytochrome P450 steroid hydroxylase genes The neo expression cassettes were removed from the targeted al-
that are involved in steroid hormone biosynthesis (Par- leles either by mating male chimeras, or their germline progeny, to
B6 CMV-cre transgenic mice. The Cre recombinase transgene wasker and Schimmer, 1997). In addition, the expression
subsequently segregated away from the Mis mutations by crossingpattern of Sf1 in the chick suggests an important role
to B6. In addition, neo was removed from an independent R1-neofor SF1 in the initiation of Mis transcription but not for its
allele in ES cells by transient expression of Cre recombinase. Cor-
upregulation (Smith et al., 1999). Taken together, these rectly targeted R1-neo clones were electroporated with 25 mg of
findings indicate that the Mis promoter receives varying supercoiled pOG231 plasmid. Cells were grown for 10 days without
transcriptional inputs depending upon the species that selection. Two hundred colonies were picked and screened by
Southern blot. One ES cell clone carrying the R1 allele in which neoresults in the same functional readout, MuÈ llerian duct
was removed in vitro contributed to the germline of chimeras. R1,regression. Because MIS has such an important and
R2, R3, and loxP animals were independently bred to homozygosityunique role in vertebrate sexual development, the Mis
and crossed to animals carrying the R1-neo allele. A final sequencing
promoter must evolve with changing circumstances. If screen for the mutations was performed on homozygous animals.
the sex determination mechanism evolves, then Mis regu-
lation must follow. RNA Analysis
Total RNA from embryonic and postpartum tissue samples was
isolated using either Qiagen RNeasy mini or midi kits, or as de-Experimental Procedures
scribed by Chomczynski and Sacchi (1987). RT±PCR was performed
using Mis primers to exon 2 (59-GAGCTCTTGCTGAAGTTC-39) andGeneration of Gene Targeting Vectors
exon 3 (59-CTGCTTGGTTGAAGGGTTAAG-39) (MuÈ nsterberg andBase pair substitutions in the nuclear hormone receptor half site
Lovell-Badge, 1991). Hprt primers (59-CCTGCTGGATTACATTAAand HMG-binding site in the Mis promoter were generated by site-
AGCACTG-39) and (5-GTCAAGGGCATATCCAACAACAAAC-39) weredirected mutagenesis by overlap extension using PCR (Ho et al.,
used as an internal control (Koopman, 1993). RNase protection1989). Wild-type control (loxP-neo) and mutant (R1-neo, R2-neo,
assays (RPA) were performed using a 315 bp PstI-SacI Mis probeand R3-neo) gene targeting vectors differing in their cis-regulatory
that overlaps the Mis transcriptional start site (Hacker et al., 1995).elements were constructed. The vectors were sequenced to confirm
The plasmid containing the probe was linearized with HindIII andthe presence of the mutations and to ensure that no other changes
transcribed using an Ambion MAXIscript T7 kit. The riboprobe waswere introduced. A floxed neo expression cassette (loxPneo-1) was
purified on a 5% polyacrylamide 8 M urea gel, excised, and elutedinserted, in reverse orientation relative to the direction of Mis tran-
from the gel with Ambion elution buffer. Between 2±3 mg of totalscription, into an SfiI site in the first intron of the loxP-neo and R1-
RNA was hybridized for 12±18 hr at 608C with 4 3 105 cpm of RNAneo targeting vectors (Figure 1B). Another floxed neo expression
probe according to the manufacturer's instructions. Samples werecassette (PGKneobpA-lox) was inserted at the identical site in intron
electrophoresed on 5% polyacrylamide 8 M urea gels. Gels were1 for the R2-neo and R3-neo targeting vectors. The exogenous
autoradiographed overnight and then exposed to PhosphoImagersequences that remain, once the PGKneobpA-lox cassette is de-
screens (Molecular Dynamics) for approximately 8 hr for quantitativeleted by Cre recombinase, are less than the residual sequence of
analysis.the loxPneo-1 cassette. The region of vector homology begins at
the XhoI site 59 of the Mis gene and extends 39 to a BamHI site,
providing 7.3 kb of total homology. The 59 arm of vector homology Acknowledgments
contains 4.0 kb from an XhoI site to the SfiI site in intron 1 and
includes the promoter mutations. The 39 arm contains a homology We thank Sara Morais da Silva and Ryohei Sekido for communicat-
ing unpublished information; David Anderson for the CMV-creof 3.3 kb from the SfiI site on intron 1 to a 39 BamHI site. A herpes
simplex virus-thymidine kinase expression cassette (pGLN-2) was (C57BL/6) transgenic mouse line; Andras Nagy for ploxPneo-1;
Steve O'Gorman for pOG231; Soazik Jamin, Sophia Tsai, and De-placed outside the 39 arm of homology to enrich for homologous
recombinants by negative selection (Mansour et al., 1988). Insertion anne Whitworth for helpful comments on the manuscript; and
Blanche Capel for discussions. These studies were supported by aof the neo cassettes brought in two unique restriction sites, EcoRI
and EcoRV, that were exploited during Southern blot analysis. grant from the National Institutes of Health (HD30284) to R. R. B.;
Cell
418
R. L.-B. is grateful for support from the UK Medical Research Council Munsterberg, A., Vivian, N., Goodfellow, P., and Lovell-Badge, R.
(1990). A gene mapping to the sex-determining region of the mouseand the Louis Jeantet Foundation. N. A. A. was supported by the
Y chromosome is a member of a novel family of embryonicallyNational Science Foundation Developmental Biology Training Grant
expressed genes. Nature 346, 245±250.BIR-9413237 and the National Institutes of Health Molecular Genet-
ics of Cancer Training Grant (CA09299). Hacker, A., Capel, B., Goodfellow, P., and Lovell-Badge, R. (1995).
Expression of Sry, the mouse sex determining gene. Development
Received August 5, 1999; revised October 14, 1999. 121, 1603±1614.
Haqq, C.M., Lee, M.M., Tizard, R., Wysk, M., DeMarinis, J., Donahoe,
References P.K., and Cate, R.L. (1992). Isolation of the rat gene for MuÈ llerian
inhibiting substance. Genomics 12, 665±669.
Arceci, R.J., King, A.A., Simon, M.C., Orkin, S.H., and Wilson, D.B. Haqq, C.M., King, C.Y., Ukiyama, E., Falsafi, S., Haqq, T.N., Donahoe,
(1993). Mouse GATA-4: a retinoic acid-inducible GATA-binding tran- P.K., and Weiss, M.A. (1994). Molecular basis of mammalian sexual
scription factor expressed in endodermally derived tissues and determination: activation of MuÈ llerian inhibiting substance gene ex-
heart. Mol. Cell. Biol. 13, 2235±2246. pression by SRY. Science 266, 1494±1500.
Baarends, W.M., Van Helmond, M.J.L., Post, M., van der Schoot, Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., and Pease, L.R.
P., Hoogerbrugge, J.W., de Winter, J.P., Uilenbroek, J., Karels, B., (1989). Site-directed mutagenesis by overlap extension using the
Wilming, L.G., Carel Meijers, J.H., et al. (1994). A novel member polymerase chain reaction. Gene 77, 51±59.
of the transmembrane serine/threonine kinase receptor family is Honda, S.-I., Morohashi, K.-I., Nomura, M., Takeya, H., Kitajima, M.,
specifically expressed in the gonads and in mesenchymal cells adja- and Omura, T. (1993). Ad4BP regulating steroidogenic P-450 gene
cent to the MuÈ llerian duct. Development 120, 189±197. is a member of steroid hormone receptor superfamily. J. Biol. Chem.
Baroiller, J.-F., Guiguen, Y., and Fostier, A. (1999). Endocrine and 268, 7494±7502.
environmental aspects of sex differentiation in fish. Cell. Mol. Life Ikeda, Y., Shen, W.H., Ingraham, H.A., and Parker, K.L. (1994). Devel-
Sci. 55, 910±931. opmental expression of mouse steroidogenic factor-1, an essential
Behringer, R.R., Cate, R.L., Froelick, G.J., Palmiter, R.D., and Brin- regulator of the steroid hydroxylases. Mol. Endocrinol. 8, 654±662.
ster, R.L. (1990). Abnormal sexual development in transgenic mice Imbeaud, S., Faure, E., Lamarre, I., Mattei, M.G., di Clemente, N.,
chronically expressing MuÈ llerian inhibiting substance. Nature 345, Tizard, R., CarreÂ -EuseÁ be, D., Belville, C., Tragethon, L., Tonkin, C.,
167±170. et al. (1995). Insensitivity to anti-MuÈ llerian hormone due to a mutation
in the human anti-MuÈ llerian hormone receptor. Nat. Genet. 11,Behringer, R.R., Finegold, M.J., and Cate, R.L. (1994). MuÈ llerian-
382±388.inhibiting substance function during mammalian sexual develop-
ment. Cell 79, 415±425. Josso, N., Cate, R.L., Picard, J.Y., Vigier, B., di Clemente, N., Wilson,
C., Imbeaud, S., Pepinsky, R.B., Guerrier, D., Boussin, L., Legeai,Call, K.M., Glaser, T., Ito, C.Y., Buckler, A.J., Pelletier, J., Haber, D.A.,
L., and CarreÂ -EuseÁ be, D. (1993). Anti-MuÈ llerian hormone: the JostRose, E.A., Kral, A., Yeger, H., Lewis, W.H., et al. (1990). Isolation and
factor. Rec. Prog. Hormone Res. 48, 1±59.characterization of a zinc finger polypeptide gene at the human
chromosome 11 Wilms' tumor locus. Cell 60, 509±520. Josso, N., Picard, J.Y., Imbeaud, S., di Clemente, N., and Rey, R.
(1997). Clinical aspects and molecular genetics of the persistentCarreÂ -EuseÁ be, D., di Clemente, N., Rey, R., Pieau, C., Vigier, B.,
MuÈ llerian duct syndrome. Clin. Endocrinol. 47, 137±144.Josso, N., and Picard, J.Y. (1996). Cloning and expression of the
Jost, A. (1953). Problems of fetal endocrinology: the gonadal andchick anti-MuÈ llerian hormone gene. J. Biol. Chem. 271, 4798±4804.
hypophyseal hormones. Rec. Prog. Hormone Res. 8, 379±418.Cate, R.L., Mattaliano, R.J., Hession, C., Tizard, R., Farber, N.M.,
Kent, J., Wheatley, S.C., Andrews, J.E., Sinclair, A.H., and Koopman,Cheung, A., Ninfa, E.G., Frey, A.Z., Gash, D.J., Chow, E.P., et al.
P. (1996). A male-specific role for SOX9 in vertebrate sex determina-(1986). Isolation of the bovine and human genes for MuÈ llerian inhib-
tion. Development 122, 2813±2822.iting substance and expression of the human gene in animal cells.
Cell 45, 685±698. Ketola, I., Rahman, N., Toppari, J., Bielinska, M., Porter-Tinge, S.B.,
Tapanainen, J.S., Huhtaniemi, I.T., Wilson, D.B., and Heikinheimo,Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA
M. (1999). Expression and regulation of transcription factors GATA-4isolation by acid guanidinium thiocyanate-phenol-chloroform ex-
and GATA-6 in developing mouse testis. Endocrinology 140, 1470±traction. Anal. Biochem. 162, 156±159.
1480.De Santa Barbara, P., Bonneaud, N., Boizet, B., Desclozeaux, M.,
Koopman, P. (1993). Analysis of gene expression by reverse tran-Moniot, B., Sudbeck, P., Scherer, G., Poulat, F., and Berta, P. (1998).
scriptase-polymerase chain reaction. In Essential DevelopmentalDirect interaction of SRY-related protein SOX9 and steroidogenic
Biology: A Practical Approach, C.D. Stern and P. W. H. Holland,factor 1 regulates transcription of the human anti-MuÈ llerian hormone
eds. (Oxford: Oxford University Press), pp. 233±242.gene. Mol. Cell. Biol. 18, 6653±6665.
Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J.,di Clemente, N., Wilson, C., Faure, E., Boussin, L., Carmillo, P.,
Housman, D., and Jaenisch, R. (1993). WT-1 is required for earlyTizard, R., Picard, J.Y., Vigier, B., Josso, N., and Cate, R. (1994).
kidney development. Cell 74, 679±691.Cloning, expression, and alternative splicing of the receptor for anti-
Lala, D.S., Rice, D.A., and Parker, K.L. (1992). Steroidogenic factorMuÈ llerian hormone. Mol. Endocrinol. 8, 1006±1020.
1, a key regulator of steroidogenic enzyme expression, is the mouseDresser, D.W., Hacker, A., Lovell-Badge, R., and Guerrier, D. (1995).
homolog of fushi tarazu-factor-1. Mol. Endocrinol. 6, 1249±1258.The genes for a spliceosome protein (SAP62) and the anti-MuÈ llerian
Lee, M.M., Seah, C.C., Masiakos, P.T., Sottas, C.M., Preffer, F.I.,hormone (AMH) are contiguous. Hum. Mol. Genet. 4, 1613±1618.
Donahoe, P.K., Maclaughlin, D.T., and Hardy, M.P. (1999). Mullerian-
Elbrecht, A., and Smith, R.G. (1992). Aromatase enzyme activity and
inhibiting substance type II receptor expression and function in
sex determination in chickens. Science 255, 467±470
purified rat Leydig cells. Endocrinology 140, 2819±2827.
Foster, J.W., Dominguez-Steglich, M.A., Guioli, S., Kwok, C., Weller, Luo, X., Ikeda, Y., and Parker, K.L. (1994). A cell-specific nuclear
P.A., Stevanovic, M., Weissenbach, J., Mansour, S., Young, I.D., receptor is essential for adrenal and gonadal development and sex-
Goodfellow, P.N., Brook, J.D., and Schafer, A.J. (1994). Campomelic ual differentiation. Cell 77, 481±490.
dysplasia and autosomal sex reversal caused by mutations in an
Lyet, L., Louis, F., Forest, M.G., Josso, N., Behringer, R.R., andSRY-related gene. Nature 372, 525±530.
Vigier, B. (1995). Ontogeny of reproductive abnormalities induced
Giuili, G., Shen, W.H., and Ingraham, H.A. (1997). The nuclear recep- by deregulation of anti-MuÈ llerian hormone expression in transgenic
tor SF-1 mediates sexually dimorphic expression of MuÈ llerian inhib- mice. Biol. Reprod. 52, 444±454.
iting substance, in vivo. Development 124, 1799±1807.
Mansour, S.L., Thomas, K.R., and Capecchi, M.R. (1988). Disruption
Goodfellow, P.N., and Lovell-Badge, R. (1993). SRY and sex determi- of the proto-oncogene int-2 in mouse embryo-derived stem cells:
nation in mammals. Annu. Rev. Genet. 27, 71±92. a general strategy for targeting mutations to non-selectable genes.
Nature 336, 348±352.Gubbay, J., Collignon, J., Koopman, P., Capel, B., Economou, A.,
Genetic Pathways of Vertebrate Sexual Development
419
Mansour, S., Hall, C.M., Pembrey, M.E., and Young, I.D. (1995). A chicken steroidogenic factor-1 during gonadal sex differentiation.
Gen. Comp. Endocrinol. 113, 187±196.clinical and genetic study of campomelic dysplasia. J. Med. Genet.
32, 415±420. Swain, A., and Lovell-Badge, R. (1999). Mammalian sex determina-
tion: a molecular drama. Genes Dev. 13, 755±767.Matzuk, M.M., Finegold, M.J., Mishina, Y., Bradley, A., and Beh-
ringer, R.R. (1995). Synergistic effects of inhibins and Mullerian- Swain, A., Zanaria, E., Hacker, A., Lovell-Badge, R., and Camerino,
inhibiting substance on testicular tumorigenesis. Mol. Endocrinol. G. (1996). Mouse Dax1 expression is consistent with a role in sex
9, 1337±1345. determination as well as in adrenal and hypothalamus function. Nat.
Genet. 12, 404±409.McMahon, A.P., and Bradley, A. (1990). The Wnt-1 (int-1) proto-
oncogene is required for development of a large region of the mouse Tremblay, J.J., and Viger, R.S. (1999). Transcription factor GATA-4
brain. Cell 62, 1073±1085. enhances MuÈ llerian inhibiting substance gene transcription through
a direct interaction with the nuclear receptor SF-1. Mol. Endocrinol.Meier, C., Partlow, G.D., Fisher, K.R.S., and Rennie, B. (1998). Persis-
tent paramesonephric ducts (masculine uterus) in the male North 13, 1388±1401.
American beaver (Castor canadensis). Can J. Zool. 76, 1188±1193. Viger, R.S., Mertineit, C., Trasler, J.M., and Nemer, M. (1998). Tran-
scription factor GATA-4 is expressed in a sexually dimorphic patternMishina, Y., Rey, R., Finegold, M.J., Matzuk, M.M., Josso, N., Cate,
R.L., and Behringer, R.R. (1996). Genetic analysis of the MuÈ llerian during mouse gonadal development and is a potent activator of the
MuÈ llerian inhibiting substance promoter. Development 125, 2665±inhibiting substance signal transduction pathway in mammalian sex-
ual differentiation. Genes Dev. 10, 2577±2587. 2675.
Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J.,Morais da Silva, S., Hacker, A., Harley, V., Goodfellow, P., Swain, A.,
and Lovell-Badge, R. (1996). Sox9 expression during development Pasantes, J., Bricarelli, F.D., Keutel, J., Hustert, E., et al. (1994).
Autosomal sex reversal and campomelic dysplasia are caused byimplies a conserved role for the gene in testis differentiation in
mammals and birds. Nat. Genet. 14, 62±68. mutations in and around the SRY-related gene SOX9. Cell 79, 1111±
1120.Morohashi, K., Honda, S., Inomata, Y., Handa, H., and Omura, T.
(1992). A common trans-acting factor, Ad4-binding protein, to the Western, P.S., Harry, J.L., Marshall Graves, J.A., and Sinclair, A.H.
promoters of steroidogenic P-450s. J. Biol. Chem. 267, 17913± (1999). Temperature dependent sex determination in the American
17919. alligator: AMH precedes SOX9 expression. Dev. Dyn. 216, 171±177.
MuÈ nsterberg, A., and Lovell-Badge, R. (1991). Expression of the Wibbels, T., Bull, J.J., and Crews, D. (1992). Steroid hormone-
mouse anti-MuÈ llerian hormone gene suggests a role in both male induced male sex determination in an amniotic vertebrate. J. Exp.
and female sexual differentiation. Development 113, 613±624. Zool. 262, 454±457.
Muscatelli, F., Strom, T.M., Walker, A.P., Zanaria, E., Recan, D., Wibbels, T., Cowan, J., and LeBoeuf, R. (1998). Temperature-depen-
Meindl, A., Bardoni, B., Guioli, S., Zehetner, G., Rabl, W., et al. (1994). dent sex determination in the red-eared slider turtle, Trachemys
Mutations in the DAX-1 gene give rise to both X-linked adrenal scripta. J. Exp. Zool. 281, 409±416.
hypoplasia congenita and hypogonadotropic hypogonadism. Na- Wilson, T.E., Fahrner, T.J., and Milbrandt, J. (1993). The orphan
ture 372, 672±676. NGFI-B and steroidogenic factor 1 establish monomer binding as
Nachtigal, M.W., Hirokawa, Y., Enyeart-VanHouten, D.L., Flanagan, a third paradigm of nuclear receptor-DNA interaction. Mol. Cell. Biol.
J.N., Hammer, G.D., and Ingraham, H.A. (1998). Wilms' tumor 1 and 13, 5794±5804.
Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific Wright, E., Hargrave, M.R., Christiansen, J., Cooper, L., Kun, J.,
gene expression. Cell 93, 445±454. Evans, T., Gangadharan, U., Greenfield, A., and Koopman, P. (1995).
Neeper, M., Lowe, R., Galuska, S., Hofmann, K.J., Smith, R.G., and The Sry-related gene Sox9 is expressed during chondrogenesis in
Elbrecht, A. (1996). Molecular cloning of an avian anti-MuÈ llerian mouse embryos. Nat. Genet. 9, 15±20.
hormone homologue. Gene 176, 203±209.
Oreal, E., Pieau, C., Mattei, M.G., Josso, N., Picard, J.Y., Carre-
Eusebe, D., and Magre, S. (1998). Early expression of AMH in chicken
embryonic gonads precedes testicular SOX9 expression. Dev. Dyn.
212, 522±532.
Parker, K.L., and Schimmer, B.P. (1997). Steroidogenic factor 1: a
key determinant of endocrine development and function. Endocr.
Rev. 18, 361±377.
Pham, C.T.N., MacIvor, D.M., Hug, B.A., Heusel, J.W., and Ley, T.J.
(1996). Long-range disruption of gene expression by a selectable
marker cassette. Proc. Natl. Acad. Sci. USA 93, 13090±13095.
Picard, J.Y., Benarous, R., Guerrier, D., Josso, N., and Kahn, A.
(1986). Cloning and expression of cDNA for anti-MuÈ llerian hormone.
Proc. Natl. Acad. Sci. USA 83, 5464±5468.
Pieau, C., Girondot, M., Desvages, G., Dorizzi, M., Mercier, R., and
Zaborski, P. (1994). Environmental control of gonadal differentiation.
In The Differences between the Sexes, R.V. Short and E. Balaban,
eds. (Cambridge: Cambridge University Press), pp. 433±448.
Racine, C., Rey, R., Forest, M.G., Louis, F., FerreÂ , A., Huhtaniemi,
I., Josso, N., and di Clemente, N. (1998). Receptors for anti-MuÈ llerian
hormone on Leydig cells are responsible for its effects on steroido-
genesis and cell differentiation. Proc. Natl. Acad. Sci. USA 5,
594±599.
Ramirez-Solis, R., Rivera-PereÂ z, J., Wallace, J.D., Wims, M., Zheng,
H., and Bradley, A. (1992). Genomic DNA microextraction: a method
to screen numerous samples. Anal. Biochem. 201, 331±335.
Shen, W.H., Moore, C.C.D., Ikeda, Y., Parker, K.L., and Ingraham,
H.A. (1994). Nuclear receptor steroidogenic factor 1 regulates the
MuÈ llerian inhibiting substance gene: a link to the sex determination
cascade. Cell 77, 651±661.
Smith, C.A., Smith, M.J., and Sinclair, A.H. (1999). Expression of
